Unichem Labs may sizzle after securing USFDA nod

Image
Capital Market
Last Updated : Dec 12 2018 | 9:04 AM IST

Unichem Laboratories received a tentative approval from the United States food and Drug Administration for its Tadalafil tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg. The announcement was made after market hours yesterday, 11 December 2018.

The board of directors of Reliance Industries accorded its approval to a scheme of arrangement for transfer of its fibre undertaking, on a going concern basis, to a separate company and a scheme of arrangement for transfer of its tower undertaking, on a going concern basis, to a separate company. The announcement was made after market hours yesterday, 11 December 2018.

Zydus Wellness (ZWL) announced that the Competition Commission of India (CCI) has granted approval for ZWL's acquisition of Heinz India jointly with Cadila Healthcare. The definitive agreement in relation to this acquisition was signed on 24 October 2018. The announcement was made after market hours yesterday, 11 December 2018.

UFO Moviez India informed about a reduction in purchase consideration for the transfer of shares of Qube Digital Cinema (QDCPL) from Nomura Asia Investment (MB) Pte., CSI BD (Mauritius), Intel Capital Corporation and/or Streetedge Capital LP to UFO Moviez India and India Advantage Fund S4 I, a fund managed by ICICI Venture Funds Management Company. The announcement was made after market hours yesterday, 11 December 2018.

PNC Infratech informed that PNC Challakere (Karnataka) Highways, the company's wholly owned subsidiary, has submitted duly executed financing documents to NHAI for the Hybrid Annuity Model (HAM) Project in Karnataka worth Rs 1157 crore. The announcement was made after market hours yesterday, 11 December 2018.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 12 2018 | 8:46 AM IST

Next Story